EVALUATING THE ASSOCIATION BETWEEN MICROSATELLITE INSTABILITY AND SOME CLINICAL AND SUBCLINICAL FEATURES OF COLORECTAL CANCER

Hoàng Hảo Dương 1, , Vinh Quang Bùi 1, Thị Hải Nguyễn 1, Thị Ngọc Nguyễn 1, Thanh Lan Đào 1
1 Hanoi Oncology Hospital

Main Article Content

Abstract

Introduction: Microsatellite instability (MSI) is one of three known molecular pathways of the pathogenesis of colorectal cancer. MSI is a prognostic indicator of colorectal cancer, which has a role in chemotherapy and immunotherapy planning, and contributes to Lynch syndrome screening. There are 3 methods to evaluate MSI status: PCR, IHC and NGS. Objective: Determine the rate of MSI and evaluate the association between MSI and some clinical and subclinical features of colorectal cancer at Hanoi Oncology Hospital. Subjects and methods: 156 patients with colorectal cancer are tested for MSI by IHC, NGS and are evaluated the association with clinical and subclinical features. Results: The rate of colorectal cancer with MSI tested by IHC is 10.9%, and by NGS is 11.5%. The sensitivity and specificity of the MSI test by IHC compared with NGS are 94.4% and 100% respectively. There is an association between MSI and: location, size, histopathological type, differentiation, microscopic invasion of the tumor and lymphocytic infiltration. This association is statistically significant with p < 0.05. There is no association between microsatellite instability and age, gender, lymph node metastasis, and distant metastasis. Conclusion: The rate of MSI testing by IHC is 10.9%, by NGS is 11.5%. The sensitivity and specificity of the MSI test by IHC compared with NGS are 94.4% and 100% respectively. There is an association between MSI and: location, size, histopathological type, differentiation, microscopic invasion of the tumor and lymphocytic infiltration.

Article Details

References

1. C. Evrard, G. Tachon, V. Randrian, L. Karayan-Tapon, và D. Tougeron, “Microsatellite Instability: Diagnosis, Heterogeneity, Discordance, and Clinical Impact in Colorectal Cancer”, Cancers, vol 11, số p.h 10, tr 1567, tháng 10 2019, doi: 10.3390/ cancers11101567.
2. Chu Văn Đ., “Nghiên cứu bộc lộ một số dấu ấn hoá mô miễn dịch và mối liên quan với đặc điểm mô bệnh học trong ung thư­­ biểu mô đại trực tràng”, Thesis, 2021. Truy cập: 12 Tháng Bảy 2023. [Online]. Available at: http://dulieuso.hmu.edu.vn/handle/hmu/1980
3. A. Sasaki và c.s., “Endoscopic Scoring System for T2 Invasion in Colorectal Cancer”, Tech. Innov. Gastrointest. Endosc., vol 24, số p.h 2, tr 121–126, tháng 1 2022, doi: 10.1016/ j.tige.2021.11.005.
4. M. E. C. McFarlane, A. Rhoden, P. R. Fletcher, và R. Carpenter, “Cancer of the colon and rectum in a Jamaican population: diagnostic implications of the changing frequency and subsite distribution”, West Indian Med. J., vol 53, số p.h 3, tr 170–173, tháng 6 2004.
5. D. Klingbiel, Z. Saridaki, A. D. Roth, F. T. Bosman, M. Delorenzi, và S. Tejpar, “Prognosis of stage II and III colon cancer treated with adjuvant 5-fluorouracil or FOLFIRI in relation to microsatellite status: results of the PETACC-3 trial”, Ann. Oncol., vol 26, số p.h 1, tr 126–132, tháng 1 2015, doi: 10.1093/annonc/mdu499.
6. A. Zaanan và c.s., “Defective Mismatch Repair Status as a Prognostic Biomarker of Disease-Free Survival in Stage III Colon Cancer Patients Treated with Adjuvant FOLFOX Chemotherapy”, Clin. Cancer Res., vol 17, số p.h 23, tr 7470–7478, tháng 12 2011, doi: 10.1158/1078-0432.CCR-11-1048.
7. R. Gafa và c.s., “Sporadic colorectal adenocarcinomas with high-frequency microsatellite instability: Pathobiologic features, hMLH1 and hMSH2 expression, and clinical outcome”, Cancer, vol 89, số p.h 10, tr 2025–2037, tháng 11 2000, doi: 10.1002/1097-0142(20001115)89:10<2025::AID-CNCR1>3.0.CO;2-S.
8. O. Suzuki và c.s., “Prevalence and clinicopathologic/molecular characteristics of mismatch repair-deficient colorectal cancer in the under-50-year-old Japanese population”, Surg. Today, vol 47, số p.h 9, tr 1135–1146, tháng 9 2017, doi: 10.1007/s00595-017-1486-x.